1363380-83-9 Usage
Uses
Used in Pharmaceutical Industry:
1-(Boc-aMino)-3,3-difluoropropane is used as a key intermediate in the synthesis of various pharmaceutical compounds for [application reason]. Its Boc-protected amino group and difluoromethyl groups provide unique structural features that can be exploited to design and develop new drugs with improved properties, such as enhanced potency, selectivity, and bioavailability.
Used in Chemical Research:
1-(Boc-aMino)-3,3-difluoropropane is used as a versatile building block in chemical research for [application reason]. Its Boc-protected amino group and difluoromethyl groups allow for the exploration of novel chemical reactions and the synthesis of complex organic molecules with potential applications in various fields, including materials science, agrochemistry, and specialty chemicals.
Used in Material Science:
1-(Boc-aMino)-3,3-difluoropropane is used as a precursor in the development of advanced materials for [application reason]. The incorporation of difluoromethyl groups into the molecular structure can impart unique properties, such as enhanced thermal stability, chemical resistance, and specific interactions with other molecules, making it suitable for applications in coatings, polymers, and other high-performance materials.
Check Digit Verification of cas no
The CAS Registry Mumber 1363380-83-9 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,3,6,3,3,8 and 0 respectively; the second part has 2 digits, 8 and 3 respectively.
Calculate Digit Verification of CAS Registry Number 1363380-83:
(9*1)+(8*3)+(7*6)+(6*3)+(5*3)+(4*8)+(3*0)+(2*8)+(1*3)=159
159 % 10 = 9
So 1363380-83-9 is a valid CAS Registry Number.
1363380-83-9Relevant academic research and scientific papers
AMIDE DERIVATIVES USEFUL IN THE TREATMENT OF HBV INFECTION OR HBV-INDUCED DISEASES
-
Page/Page column 62, (2020/09/08)
The application relates to amide derivatives, processes for their preparation, pharmaceutical compositions, and their uses, more particularly their uses in treating chronic hepatitis B virus (HBV) infection.
SUBSTITUTED PYRROLIZINE COMPOUNDS AS HBV REPLICATION INHIBITORS
-
Paragraph 0262; 0270; 0306; 0307, (2019/09/12)
This application relates generally to certain substituted pyrrolizine compounds, and pharmaceutical compositions which inhibit HBV replication, and methods of making and using them.
SUBSTITUTED PYRROLIZINE COMPOUNDS AND USES THEREOF
-
Paragraph 0229, (2018/03/25)
This application relates to substituted fused pyrrole compounds of formula I, and pharmaceutical compositions comprising them which inhibit HBV replication, and methods of making and using them. Formula (I)
COMPOUNDS AND COMPOSITIONS AS C-KIT KINASE INHIBITORS
-
Paragraph 0543-0551, (2013/03/26)
The invention provides compounds and pharmaceutical compositions thereof, which are useful as protein kinase inhibitors, as well as methods for using such compounds to treat, ameliorate or prevent a condition associated with abnormal or deregulated kinase activity. In some embodiments, the invention provides methods for using such compounds to treat, ameliorate or prevent diseases or disorders that involve abnormal activation of c-kit or c-kit and PDGFR (PDGFRα, PDGFRβ) kinases.
